CONNECT WITH US
Tech

Tech

Why Unilever acquired Grüns and Dr. Squatch

Fast Company logo

Published on

Add as a preferred source on Google
Why Unilever acquired Grüns and Dr. Squatch

Hello and welcome to Modern CEO! I’m Stephanie Mehta, CEO and chief content officer of Mansueto Ventures. Each week this newsletter explores inclusive approaches to leadership drawn from conversations with executives and entrepreneurs, and from the pages of Inc. and Fast Company. If you received this newsletter from a friend, you can sign up to get it yourself every Monday morning. 

During the past decade, the British consumer goods giant Unilever has undergone a transformation. The conglomerate shed its food businesses, selling its margarine and spreads business to KKR in 2019, spinning off Magnum Ice Cream in 2025, and announcing plans to combine its remaining food portfolio—including the Hellmann’s and Knorr brands—with the spice maker McCormick in a transaction that reflects an enterprise value for Unilever of $44.8 billion. The deal is expected to close next year.  

The result will be an enterprise that is a pure play in the personal care, beauty, and wellness spaces. Unilever boasts a mix of legacy brands such as Vaseline and newer entrants such as Grüns, the gummy supplement company Unilever acquired earlier this year for a reported $1.2 billion. “Unilever U.S. will become a focused $9.4 billion business, operating in attractive, fast-growing segments,” says Herrish Patel, president of Unilever USA and CEO of Unilever Personal Care North America. “We have a beautiful stable of brands.” 

” Dove has attracted new users through offbeat collabs with the Netflix bodice-ripper TV show Bridgerton (“The royal treatment every queen deserves”) and Crumbl, a cookie chain.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.